IP Library Granted Patent US 9,731,045
Granted Patent B2
US 9,731,045 · App. 14/148,617 · Granted Aug 15, 2017

Shape memory polymer

Inventors: Kenneth Gall (Atlanta, GA); Christopher Yakacki (Denver, CO)
Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO
A61L27/16A61B17/0401A61F2/0811A61L27/50A61B2017/00871A61B2017/0448A61F2002/0835A61F2002/0858A61F2002/0864A61F2002/0882A61F2002/0888A61F2210/0014A61L2400/16A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,731,045
App. No.
14/148,617
Granted
Aug 15, 2017
Kind
B2
Abstract

A polymer is composed of a linear chain acrylate and a multi-functional acrylate cross-linker. The polymerized composition exhibits a transition at a temperature between about 34° C. and about 50° C. The polymerized composition exhibits shape memory effects. In one embodiment, the linear chain is tert-butyl acrylate and the crosslinker is polyethylene glycol dimethacrylate. The resultant shape memory polymers may be used in medical devices to provide devices with different shapes for pre and post implantation.

Claims (32)

1. An amorphous polymerized composition comprising

a linear chain comprising tert-butyl acrylate; and

a first cross-linker comprising polyethylene glycol dimethacrylate; wherein

the amorphous polymerized composition exhibits a glass transition at a temperature between about 34° C. and about 50° C., inclusive;

the amorphous polymerized composition comprises 5% to 80% by weight of the polyethylene glycol dimethacrylate; and

the amorphous polymerized composition exhibits shape memory effects.

2. The amorphous polymerized composition of claim 1 further comprising a photoinitiator.

3. The amorphous polymerized composition of claim 1 comprising more than about 10% by weight of the polyethylene glycol dimethacrylate.

4. The amorphous polymerized composition of claim 1 , wherein the shape memory polymer comprises 20% by weight of polyethylene glycol dimethacrylate.

5. The amorphous polymerized composition of claim 1 , wherein the glass transition temperature is about 37° C.

6. The amorphous polymerized composition of claim 2 , wherein the photoinitiator comprises 2,2-dimethoxy-2-phenylacetophen one.

7. The amorphous polymerized composition of claim 1 , wherein a recovery time of the amorphous polymerized composition is between 10 seconds and 10 minutes.

8. A device for in vivo medical applications comprising

a chemically-cross-linked, shape memory polymer comprising

tert-butyl acrylate as a first monomer; and

polyethylene glycol dimethacrylate as a second chemically crosslinking monomer; wherein

the shape memory polymer comprises 5% to 80% by weight of polyethylene glycol dimethacrylate;

the shape memory polymer has a glass transition temperature between about 34° C. and 50° C., inclusive;

the device is formed of the shape memory polymer in an original shape;

the device is deformed from the original shape for use in the in vivo medical application; and

the device recovers to the original shape upon being placed in vivo at body temperature.

9. The device of claim 7 , wherein the shape memory polymer comprises 20% by weight of polyethylene glycol dimethacrylate.

10. The device of claim 7 further comprising a photoinitiator.

11. The device of claim 10 , wherein the photoinitiator is 2,2-dimethoxy-2-phenylacetophenone.

12. The device of claim 7 , wherein the shape memory polymer has a glass transition temperature of about 37° C.

13. The device of claim 7 , wherein the shape memory polymer an elastic modulus between 0.5 MPa and 20 MPa, inclusive.

14. The device of claim 7 , wherein a recovery time of the shape memory polymer is between 10 seconds and 10 minutes.

15. The device of claim 7 , wherein recovery time of transformation of the shape memory polymer is a function of a deformation temperature (T d ).

16. The device of claim 7 , wherein the shape memory polymer further comprises a hydrogel material.

17. The device of claim 14 , wherein

the recovery time is a function of an amount of the polyethylene glycol dimethacrylate in the shape memory polymer.

18. The device of claim 7 , wherein selection of an amount of polyethylene glycol dimethacrylate changes the glass transition temperature.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2017
From: GALL, KENNETH; YAKACKI, CHRISTOPHER
To: COLORADO, THE REGENTS OF THE UNIVERSITY OF
Reel/Frame 042956/0586 →
CONFIRMATORY LICENSE Recorded Sep 30, 2014
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033848/0073 →
Continuity (4)
Continuation 13730570 · Dec 28, 2012
Division 10598080
Provisional Application 60667876 · Apr 1, 2005
Related Publication 20140121295A1 · May 1, 2014